INTERIM RESULTS OF A PHASE II STUDY OF FONDAZIONE ITALIANA LINFOMI ON GEMCITABINE PLUS ROMIDEPSIN IN RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA PATIENTS

被引：0

作者：

Pellegrini, C. ^{[1
]}

Broccoli, A. ^{[1
]}

Casadei, B. ^{[1
]}

Chiappella, A. ^{[2
]}

Corradini, P. ^{[3
]}

Derenzini, E. ^{[1
]}

Dodero, A. ^{[3
]}

Farina, L. ^{[3
]}

Gandolfi, L. ^{[1
]}

Ladetto, M. ^{[4
]}

Monaco, F. ^{[4
]}

Orsucci, L. ^{[2
]}

Quirini, F. ^{[1
]}

Salvi, F. ^{[4
]}

Spina, F. ^{[3
]}

Stefoni, V. ^{[1
]}

Tonialini, L. ^{[1
]}

Vitolo, U. ^{[2
]}

Argnani, L. ^{[1
]}

Cavo, M. ^{[1
]}

Zinzani, P. L. ^{[1
]}

机构：

[1] Univ Bologna, Inst Hematol L & A Seragnoli, Bologna, Italy

[2] Azienda Osped Univ Citta Salute & Sci Torino, Hematol, Turin, Italy

[3] Fdn IRCCS Ist Nazl Tumori, Hematol, Milan, Italy

[4] SS Antonio & Biagio Hosp Alessandria, Hematol, Alessandria, Italy

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C029

引用

页码：18 / 19

页数：2

共 50 条

[1] Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients
Pellegrini, Cinzia
Broccoli, Alessandro
Casadei, Beatrice
Chiappella, Annalisa
Corradini, Paolo
Derenzini, Enrico
Dodero, Anna
Farina, Lucia
Gandolfi, Letizia
Ladetto, Marco
Monaco, Federico
Orsucci, Lorella
Quirini, Federica
Salvi, Flavia
Spina, Francesco
Stefoni, Vittorio
Tonialini, Lorenzo
Vitolo, Umberto
Argnani, Lisa
Zinzani, Pier Luigi
BLOOD, 2015, 126 (23)
[2] A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
Cinzia Pellegrini
Anna Dodero
Annalisa Chiappella
Federico Monaco
Debora Degl’Innocenti
Flavia Salvi
Umberto Vitolo
Lisa Argnani
Paolo Corradini
Pier Luigi Zinzani
Journal of Hematology & Oncology, 9
[3] A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
Pellegrini, Cinzia
Dodero, Anna
Chiappella, Annalisa
Monaco, Federico
Degl'Innocenti, Debora
Salvi, Flavia
Vitolo, Umberto
Argnani, Lisa
Corradini, Paolo
Zinzani, Pier Luigi
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[4] BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED/REFRACTORY CD30 POSITIVE PERIPHERAL T-CELL LYMPHOMA PATIENTS: A PHASE 2 STUDY OF THE FONDAZIONE ITALIANA LINFOMI
Carella, M.
Pellegrini, C.
Corradini, P.
Orsucci, L.
Volpetti, S.
Argnani, L.
Dodero, A.
Stefoni, V.
Zinzani, P. L.
HAEMATOLOGICA, 2021, 106 (10) : 70 - 70
[5] Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana Linfomi
Cavallo, Federica
Clerico, Michele
Lucchini, Elisa
Castiglione, Anna
Re, Alessandro
Zilioli, Vittorio Ruggiero
Visco, Carlo
Tani, Monica
Olivieri, Jacopo
Arcaini, Luca
Fabbri, Alberto
Gaidano, Gianluca
Dodero, Anna
Zaja, Francesco
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1404 - 1410
[6] Brentuximab Vedotin As Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T-Cell Lymphoma Patients: A Phase 2 Study of the Fondazione Italiana Linfomi
Stefoni, Vittorio
Corradini, Paolo
Orsucci, Lorella
Volpetti, Stefano
Argnani, Lisa
Dodero, Anna
Pellegrini, Cinzia
Zinzani, Pier Luigi
BLOOD, 2020, 136
[7] Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
Maruyama, Dai
Tobinai, Kensei
Ogura, Michinori
Uchida, Toshiki
Hatake, Kiyohiko
Taniwaki, Masafumi
Ando, Kiyoshi
Tsukasaki, Kunihiro
Ishida, Takashi
Kobayashi, Naoki
Ishizawa, Kenichi
Tatsumi, Yoichi
Kato, Koji
Kiguchi, Toru
Ikezoe, Takayuki
Laille, Eric
Ro, Tokihiro
Tamakoshi, Hiromi
Sakurai, Sanae
Ohtsu, Tomoko
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (05) : 655 - 665
[8] Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi
Zaja, Francesco
Salvi, Flavia
Franceschetti, Silvia
Gaidano, Gianluca
Ladetto, Marco
Zanni, Manuela
Pica, Gian Matteo
Carella, Angelo Michele
Chiappella, Annalisa
Volpetti, Stefano
Zinzani, Pier Luigi
D'Arco, Alfonso Maria
Evangelista, Andrea
Tucci, Alessandra
Piccaluga, Pier Paolo
Pileri, Stefano A.
Fanin, Renato
Levis, Alessandro
BLOOD, 2013, 122 (21)
[9] Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study
Dai Maruyama
Kensei Tobinai
Michinori Ogura
Toshiki Uchida
Kiyohiko Hatake
Masafumi Taniwaki
Kiyoshi Ando
Kunihiro Tsukasaki
Takashi Ishida
Naoki Kobayashi
Kenichi Ishizawa
Yoichi Tatsumi
Koji Kato
Toru Kiguchi
Takayuki Ikezoe
Eric Laille
Tokihiro Ro
Hiromi Tamakoshi
Sanae Sakurai
Tomoko Ohtsu
International Journal of Hematology, 2017, 106 : 655 - 665
[10] Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Ogura, Michinori
Maruyama, Dai
Tobinai, Kensei
Uchida, Toshiki
Hatake, Kiyohiko
Taniwaki, Masafumi
Ando, Kiyoshi
Tsukasaki, Kunihiro
Ishida, Takashi
Kobayashi, Naoki
Ishizawa, Kenichi
Tatsumi, Yoichi
Kato, Koji
Kiguchi, Toru
Ikezoe, Takayuki
Laille, Eric
Ro, Tokihiro
Tamakoshi, Hiromi
Sakurai, Sanae
Ohtsu, Tomoko
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →